Hypha Labs

Hypha Labs EBITDA per Share

The EBITDA per Share of Hypha Labs (FUNI) as of Oct 21, 2026 is -0.02 USD. In the previous year, EBITDA per Share was -0.01 USD — a change of 79.54% (lower).

EBITDA per Share

-0.02USD

YoY

79.54%

Last updated:

EBITDA per Share of Hypha Labs is 2025 -0.02 USD. EBITDA per Share of Hypha Labs was 2024 -0.01 USD. It decreases by 79.54% lower compared to the previous year.

The Hypha Labs EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.04 USD
Jan 1, 2019
-0.04 USD
Jan 1, 2020
-0.04 USD
Jan 1, 2021
-0.01 USD
Jan 1, 2022
-0.02 USD
Jan 1, 2023
-0.00 USD
Jan 1, 2024
-0.01 USD
Jan 1, 2025
-0.02 USD
The Hypha Labs EBITDA per Share history
YEAREBITDA per ShareYoY
-0.02USD+79.54%
-0.01USD+201.49%
-0.00USD-84.48%
-0.02USD+120.45%
-0.01USD-71.17%
-0.04USD-2.93%
-0.04USD-7.49%
-0.04USD+12.46%
-0.04USD-66.74%
-0.11USD-51.82%
-0.23USD-48.52%
-0.44USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hypha Labs Stock analysis

What does Hypha Labs do? Hypha Labs Inc operates through its subsidiary Digipath Labs, Inc., providing cannabis testing services using FDA-compliant equipment to detect contaminants like pesticides, heavy metals, and microbial toxins for growers, dispensaries, and producers. The company offers data analytics and education services alongside testing, targeting cannabis industry stakeholders including patients and end users. Its business model relies on third-party testing contracts from cannabis businesses and data analytics subscriptions, with revenue generated from laboratory services and educational content for industry professionals. Digipath Labs screens medicinal and recreational cannabis for harmful contaminants including residual solvents, moisture, and aflatoxins, serving a range of clients from cultivators to dispensaries. The company's analytics and training services complement its core testing business, creating multiple revenue streams within the cannabis testing sector. Revenue is derived from testing fees, data analytics packages, and educational programs tailored to cannabis industry participants. Hypha Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypha Labs stock

EBITDA per Share of Hypha Labs is -0.02 USD in 2025.

EBITDA per Share of Hypha Labs changed from -0.01 USD to -0.02 USD, representing a 79.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Hypha Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hypha Labs

All Key Metrics — Hypha Labs